Tectonic Therapeutic | AVRO - Operating Expenses

Stock Price
33.31
Daily Change
-0.81 -2.37%
Monthly
57.94%
Yearly
29.96%
Q1 Forecast
32.30

Tectonic Therapeutic reported $21.89M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Akebia Therapeutics USD 43.82M 16.98M Mar/2025
Alnylam Pharmaceuticals USD 965.32M 84.27M Dec/2025
Celltrion KRW 724.99B 6B Sep/2025
Cspc Pharmaceutical CNY 5.4B 298.41M Sep/2025
Deva Holding AS TRY 1.35B 178.26M Sep/2023
Dianthus Therapeutics USD 40.68M 5.56M Sep/2025
Divis Laboratories Ltd INR 18.32B 1.08B Dec/2025
Gilead Sciences USD 4.96B 707M Dec/2025
Ionis Pharmaceuticals USD 418M 101.1M Dec/2025
Kangmei Pharma CNY 1.39B 144.29M Sep/2025
Karyopharm Therapeutics USD 61.82M 3.24M Dec/2024
Knight Therapeutics CAD 89.06M 2.02M Sep/2024
Laboratorios Farma EUR 313.62M 17.98M Dec/2023
MacroGenics USD 67M 8M Sep/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 21.61M 11.59M Dec/2025
Neuren Pharmaceuticals AUD 25.23M 16.54M Dec/2025
Organigram Holdings CAD 108.11M 17.03M Sep/2025
Ovoca Bio EUR 5.65M 3.45M Jun/2022
Pfizer USD 12.91B 79.89B Dec/2025
Pharma Mar EUR 46.87M 7.24M Dec/2025
Qiagen NV USD 418.54M 23.25M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sangamo BioSciences USD 33.87M 12.89M Jun/2024
Sanofi EUR 10.51B 1.21B Dec/2025
Sarepta Therapeutics USD 853.02M 390.78M Dec/2025
Sartorius EUR 693.1M 29.4M Sep/2025
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Takeda JPY 1.02T 400.98B Dec/2025
Tilray USD 237.52M 17.34M Sep/2025
Zz Pientze Pharmaceu CNY 1.55B 129.66M Sep/2025